SynthesisMedicine2026
Curative effect of acupuncture combined with Chinese medicine on cancer pain: Systematic review and meta-analysis.
Synthesis in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer and cancer pain caused by treatment have brought great challenges. With the increasing number of papers on the treatment of cancer pain with acupuncture combined with Chinese medicine, this paper aims to evaluate the evidence of the association of acupuncture combined with Chinese medicine with reduction in cancer pain.
methodFour English databases and 4 Chinese databases were systematically searched from the establishment of the database to September 18, 2024. Randomized clinical trials that compared acupuncture combined with Chinese medicine with acupuncture alone, analgesic therapy, or other usual care for cancer pain were included. Data were screened and extracted independently using predesigned forms. The quality of randomized controlled trials (RCTs) was appraised with the Cochrane Collaboration risk of bias tool with Rvman 5.4 software. According to the different types of data,count data used risk ratioas the effect sizes, and Measurement data used Mean difference (MD)as the effect sizes and standardized MD.
resultsTen RCTs (comprising 884 participants) were incorporated into the systematic review, with data from all ten trials included in the meta-analysis. Findings from 7 of the trials indicated that the combination of acupuncture and Chinese medicine, when compared to other forms of care, led to a decrease in pain intensity. A good analgesic efficacy was seen by using the acupuncture combined with Chinese medicine in 6 RCTs (MD, 1.22 points; 95% confidence interval [CI], 1.12 to 1.32;Ⅰ2 = 13%). Two RCTs showed that acupuncture combined with Chinese medicine and tertiary analgesic therapy could shorten the onset time of analgesics(MD, -14.82 points;95% CI, -16.80 to -12.82;Ⅰ2 = 0%); and 3 RCTs increased the duration of analgesia(MD, 2.40 points;95% CI, 2.01 to 3.82;Ⅰ2 = 95%). An improvement in the quality of life of the cancer patients was seen when acupuncture combined with Chinese medicine was used in 5 RCTs (MD, 4.68 points;95% CI, 3.69 to 5.66;Ⅰ2 = 0%).
conclusionThe systematic review and meta-analysis conducted that a significant reduction in cancer pain was observed in patients who received acupuncture combined with Chinese medicine, compared to those who received other treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.